Who is affected by the new policy?
Any researcher submitting a proposal to NIH on or after January 25, 2023. This includes researchers all over the University of Utah campus. In addition new policies exist for specific situations:
àGenomic Data Sharing Policy
àModel Organisms Sharing Policy
àResearch Tools Policy
àHuman Data Sharing including the Requirements for Registering & Reporting NIH-funded Clinical Trials in ClinicalTrials.gov
In simple terms what is the policy?
The Data Management and Sharing Plan, DMS is documentation of how you will manage and share your scientific data
and any accompanying metadata, while taking into account any potential restrictions or limitations. The plan is expected to be dynamic, i.e., changes may need to be made while conducting the research. The funding institute or center will need to approve the changes. Speak to your Program Officer.
The 2003 NIH Data Sharing Policy required a plan for sharing the data or justify for not sharing the data. NIH has expanded that policy to include documentation of how you will manage research outcomes during the project and after it has been completed. In addition, the policy for sharing of publications resulting from the research has been as is still in effect since 2003. For a refresher on sharing publications see When and How to Comply.
The DMS is the documentation of the work you have always performed prior to submitting any other NIH grant to determine costs and timeline, for example –
NIH has assembled information on the best practices for scientific data management for your education.
Why is NIH initiating this change?
In short, the NIH believes that sharing scientific data accelerates biomedical research discovery, in part, by enabling validation of research results, providing accessibility to high-value datasets, and promoting data reuse for future research studies. In addition, the world has been moving towards open research/science which means freely sharing the results of all research. UNESCO signed the Recommendation on Open Science in November 2021.
What is scientific data?
It is the same as the White House, Office of Management and Budget definition recorded in Circular A-110:
The recorded factual material commonly accepted in the scientific community as of sufficient quality to validate and replicate research findings, regardless of whether the data are used to support scholarly publications. Scientific data do not include laboratory notebooks, preliminary analyses, completed case report forms, drafts of scientific papers, plans for future research, peer reviews, communications with colleagues, or physical objects, such as laboratory specimens.
Read the NIH overall instructions for your Data Management and Sharing Plan. In addition (1) check the funding institute or center to see if they have additional requirements, (2) determine where you will publish articles resulting from the work and check the journal’s requirements for the data and metadata, and (3) determine which repository you will submit your data/metadata to and learn of their requirements (see Repositories for Sharing Scientific Data).
The National Academies of Sciences Engineering and Medicine produced a report Life-Cycle Decisions for Biomedical Data: The Challenge of Forecasting Costs you can acquire from the National Academies Press. You can pay for a hard copy or download a free pdf. Login required. In addition, NIH has produced a guide notice, Supplemental Policy Information: Allowable Costs for Data Management and Sharing Notice Number: NOT-OD-21-015 describing allowable costs. Also see Budgeting for Data Management and Sharing
Checklist for the Data Management and Sharing Plan
In general the plan should describe what data will be generated and how the research group will manage, store, and disseminate data generated (from Notice Number: NOT-HS-20-011):
1. Types of primary data, samples, physical collections, software, curriculum materials, etc., (e.g., digital numeric data, photographs, video, acoustic records, database tables, spreadsheets, paper records, physical samples, etc.), which are produced during the project; necessary data flow, and produces the data entry/tracking plan.
2. What metadata the proposed research will generate and how the metadata will be captured and structured (e.g., in Word document, tab on data spreadsheet).
3. Tools, e.g., a template that will be employed to capture metadata consistently through the search.
4. The metadata standard(s) or formats to be used or considered to represent data and metadata elements in the data collection, including any modifications of the standard(s).
5. The volume of data that is anticipated to be collected and growth to help understand the amount of digital storage space required during the course of the research.
6. The anticipated time frame of the research effort in relation to the duration when digital storage space will be required.
7. Indicate how the scientific data will be made discoverable and whether a persistent unique identifier or other standard indexing tools will be used, and whether the data contain Personally Identifiable Information or any information whose distribution may be restricted by law or national security.
8. Indicate whether scientific data generated from humans or human biospecimens will be available through unrestricted (made publicly available to anyone) or restricted access (made available after the requestor has received approval to use the requested scientific data for a particular project or projects). If the scientific data will be shared through a restricted access mechanism, describe the terms of access for the data.
9. If applicable, any documentation on specific terminology or guidance on valid values (e.g., “t” = time), and include or reference that documentation.
10. Where and how the data will be stored initially (i.e., prior to being sent to a long-term archive facility), such as the use of data repositories.
11. The minimum preservation time afforded by the proposed budget.
12. Describe any future decision points regarding continued preservation, archiving, or retiring the data
13. Describe any provisions for maintaining the security and integrity of the scientific data (e.g., encryption and backups, how the data will be protected from accidental or malicious modification or deletion, including data back-up, disaster recovery/contingency planning, and off-site storage relevant to the data collection).
14. The quality control procedures, and the overall lifecycle of the data from collection or acquisition to making it available to the public and other researchers.
15. The plan for addressing the study participants’ consent process to enable the de-identified data to be shared broadly for future research.
16. The copyright and the intellectual property rights of the data. If applicable, indicate how intellectual property, including invention or other proprietary rights, will be managed in a way to maximize sharing of scientific data. Include any information relevant to the intellectual property rights associated with the scientific data, such as whether the intellectual property stems from an existing agreement or is anticipated to arise from the proposed research project itself.
17. An estimated cost to implement the data management plan. This cost is allowable as part of the grant award direct costs or contract award price. Any costs associated with implementing the DMP should be explained in the Budget Justification.
18. Address the roles and responsibilities of all parties with respect to the management of the data (including contingency plans for the departure of key personnel from the project) after the grant or research contract ends.
19. Explain how the recipient plans to manage and disseminate data generated by the project.
20. Describe how you will check for adherence to this DMP. Indicate the party responsible for managing the data.
21. If data will not be available to the public, describe why data will be closed or limited. Note any ethical or legal reasons for limited public access.
22. Describe any existing data sharing agreement(s), outlining the responsibilities of each party, as well as how scientific data can and cannot be used.
23. Describe any existing general licensing terms, and any limitations on the scientific data use and reuse based on these terms. Describe whether the licensing is imposed by the applicant institution or whether it comes from any existing agreement(s).
24. Describe alternative plans for maintaining, preserving, and providing access to scientific data should the original Plan not be achieved.
25. Other Considerations: Indicate whether additional considerations are needed to preserve and make accessible implement the scientific data. Plan (e.g., prior permission to use a specific repository
At this point in time the NIH is saying:
NIH will monitor compliance with Plans over the course of the funding period during regular reporting intervals (e.g., at the time of annual Research Performance Progress Reports (RPPRs)). Noncompliance with Plans may result in the NIH ICO adding special Terms and Conditions of Award or terminating the award. If award recipients are not compliant with Plans at the end of the award, noncompliance may be factored into future funding decisions.
These DMS are not expected to be long narratives so 2-pages or less is appropriate.